Pelton, Gregory H; Soleimani, Laili; Roose, Steven P et al. (2016) Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study. Alzheimer Dis Assoc Disord 30:67-9
|
Devanand, D P; Bansal, Ravi; Liu, Jun et al. (2012) MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage 60:1622-9
|
Albers, Mark W; Tabert, Matthias H; Devanand, D P (2006) Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep 6:379-86
|
Tabert, Matthias H; Liu, Xinhua; Doty, Richard L et al. (2005) A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol 58:155-60
|
Tabert, M H; Albert, S M; Borukhova-Milov, L et al. (2002) Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 58:758-64
|
Albert, Steven M; Tabert, Matias H; Dienstag, Alan et al. (2002) The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep 4:64-8
|
Devanand, D P; Michaels-Marston, K S; Liu, X et al. (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157:1399-405
|
Albert, S M; Michaels, K; Padilla, M et al. (1999) Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry 7:213-20
|
Devanand, D P (1999) The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Alzheimer Dis Assoc Disord 13 Suppl 2:S3-8
|
Devanand, D P; Marder, K; Michaels, K S et al. (1998) A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 155:1512-20
|
Showing the most recent 10 out of 11 publications